Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06597994

Augmenting Urinary Reflex Activity: Study 3

Therapy Optimisation Study of Adaptive Pudendal Neuromodulation in Women With Urinary Incontinence Implanted With the Amber UI System.

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
12 (estimated)
Sponsor
Amber Therapeutics Ltd · Industry
Sex
Female
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

AURA-3 study (Augmenting Urinary Reflex Activity Study 3) is a single arm, short-duration (8 month) cohort follow up study of preceding interventional medical device study, AURA-2.

Conditions

Interventions

TypeNameDescription
DEVICEAmber UI systemUpgrade of Amber UI system recharge accessories and system firmware

Timeline

Start date
2025-01-15
Primary completion
2026-01-01
Completion
2026-01-01
First posted
2024-09-19
Last updated
2025-05-15

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT06597994. Inclusion in this directory is not an endorsement.